WuXi Biologics (Cayman) Inc. (FRA:1FW2)

WuXi Biologics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,426	8,966	14,476	30,347	44,084	44,275
Market Cap Growth	67.98%	-38.06%	-52.30%	-31.16%	-0.43%	203.05%
Enterprise Value	14,024	8,835	14,219	29,722	42,867	44,097
Last Close Price	3.50	2.17	3.36	7.20	-	-
PE Ratio	28.92	20.19	33.37	50.61	93.99	209.36
PS Ratio	6.05	3.63	6.66	14.65	30.95	63.00
PB Ratio	2.47	1.49	2.58	6.18	9.74	16.92
P/TBV Ratio	2.82	1.70	2.96	6.79	10.56	17.69
P/FCF Ratio	68.99	52.62	182.37	-	-	-
P/OCF Ratio	21.21	12.99	24.31	40.37	92.82	187.95
EV/Sales Ratio	5.78	3.58	6.54	14.35	30.10	62.75
EV/EBITDA Ratio	16.65	11.42	22.61	43.22	85.50	198.82
EV/EBIT Ratio	21.11	14.56	28.34	50.36	97.69	234.41
EV/FCF Ratio	67.07	51.85	179.13	-	-	-
Debt / Equity Ratio	0.10	0.11	0.10	0.12	0.13	0.16
Debt / EBITDA Ratio	0.73	0.82	0.89	0.86	1.18	1.85
Debt / FCF Ratio	2.90	3.84	7.33	-	-	-
Asset Turnover	0.34	0.33	0.32	0.33	0.28	0.24
Inventory Turnover	6.36	6.71	5.04	4.31	3.94	4.15
Quick Ratio	2.40	1.98	2.35	1.56	1.85	2.49
Current Ratio	2.88	2.73	2.78	1.98	2.37	3.16
Return on Equity (ROE)	10.51%	8.82%	8.90%	13.20%	13.09%	10.02%
Return on Assets (ROA)	5.89%	5.05%	4.63%	5.81%	5.43%	4.03%
Return on Capital (ROIC)	6.64%	5.79%	5.51%	7.00%	6.47%	4.78%
Return on Capital Employed (ROCE)	10.60%	9.50%	8.00%	10.80%	8.90%	6.10%
Earnings Yield	3.46%	4.95%	3.00%	1.98%	1.06%	0.48%
FCF Yield	1.45%	1.90%	0.55%	-0.15%	-0.97%	-1.17%
Buyback Yield / Dilution	2.55%	2.80%	0.62%	1.04%	-5.05%	-5.30%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.